My Medication Side Effects Are Too Popular

惺瑞

Since Pfizer was cleaned up once by Fu Liang, it has fully developed the generic drug business and made it its current main business.

To this end, it has also acquired several pharmaceutical companies and obtained some generic drug technologies and patent authorizations.

Although the profit of this business is relatively low, the average is about [-]%, which is far less than Pfizer's original net profit margin of more than [-]%

But compared to watching revenue continue to decline, this can at least ensure that the company makes money.

Sun Pharmaceutical also wants to be like Pfizer,

More than $[-] billion of generic drugs are sold a year, and more

In this way, all the shareholders can share the money, and there will be more

At that time, the company's stock price will continue to rise, and their net worth will also soar.

"A shareholder waved at Lacus with a very proud face.

"Lacus, goodbye

After Lacus leaves, he will take over the position of president of Sun Pharmaceutical, and of course he is in a good mood.

Rakus Khan looked at each other: "Do you really think your goal can be achieved? It seems that you still don't understand Fu Liang.

- A person who can make the political axe of the East come forward for him, will it be so easy to forget?

So much thunder and so little rain?

Fu Gao must have a backhand.

That is a ruthless man who made the market value of listed pharmaceutical companies in the world drop by more than [-]% with one blow!

"Lacus, what do you mean? Are you still dissatisfied with everyone's decision?"

"Think about your son, he has taken care of us a lot, and your loss is not big. And you, as the president, have problems with the operation of the company

You are supposed to be responsible!

Lakus Khan shook his head: "You let me take the blame, I know I can't resist. But you think this is over, it's really naive.

"Look, Sun Pharmaceutical will definitely be hit hard!

A person hurried in and shouted: "No, Xinming Pharmaceutical and Cipla announced a cooperation."

Just talking,

"They licensed the 3.2 patent of Lung Cancer Clear to Cipla, and they also bought some patent licenses from some pharmaceutical companies in the East and sold them to Cipla.

"The treatment direction of many of these drugs overlaps with ours, and the effect is better than ours.

"Cardiovascular, anti-inflammatory drugs, antihypertensive drugs, lipid-lowering drugs, and special drugs for pain treatment are all available, completely covering our drug treatment direction.

Lacus Khan laughed: "If you didn't let me take the blame, I would have been sure to get Fu Liang's forgiveness.

"But now, with your attitudes, Fu Liang will not give you any more chances.

"Sun Pharmaceutical is about to be destroyed in your hands.

After Lakus Khan went out, his mood became low again by the way.

Sun Pharmaceutical was also destroyed in his hands!

Chapter [-]: They will suffer within three days, I said!

Fu Liang had said before that to see which pharmaceutical company on Asan's side could give him satisfactory conditions, he didn't mind patent licensing.

Anyway, in Asan's market, no pharmaceutical company can make big money.

This is the case in the industry. In some markets, it may only occupy less than half of the world's population, or even less, but it can bring more than [-]% of the profits.

And some markets have a very large population, but they can't make any money at all.

Cipra was the first to understand what Fu Liang meant, and the chairman came to discuss patent licensing in person

They promised that the medicines would only be sold in their own countries, and if they wanted to sell them abroad, they would have to get Fu Liang's consent first, even in some African regions.

They also don't take advantage of them.Selling drugs for profit by means of drug exchange and other methods ensures that Fu Liang's interests are not damaged.

Even if it is sold domestically, half of the retail price will be counted as royalties and handed over to Fu Liang.

Instead of talking about how much, but directly talking about the ratio, Fu Liang is most satisfied.

At that time, even if they sell a box of 11 dollars, then Fu Liang will get [-] dollars of patent licensing fee, instead of the dozen or so promised by Sun Pharma.

A few hundred dollars to treat lung cancer is extremely cheap in the world.

Fu Liang believes that Cipra will not be sold so cheaply, and he will get more.

When talking about cracking down on Sun Pharmaceutical, the chairman of Cipla was also very happy.

He even helped Fu Liang come up with ideas. After all, Cipra used to be the leader of the pharmaceutical company on Asan's side.

If it weren't for the support of the top, how could Sun Pharmaceutical be able to overtake?

There is indeed some tacit understanding between them, the top pharmaceutical companies of Asan, but there is also competition.

Cipla expressed the hope to obtain more patent drug authorizations from eastern pharmaceutical companies, but they did not have the ability to obtain

After all, many drugs are not emergency life-saving drugs, and Asan's pharmaceutical companies cannot obtain compulsory patent licenses.

Fu Liang did a favor and bought some patent licenses from several large domestic pharmaceutical companies such as Bingcheng Pharmaceutical Group, and only authorized Asan's side.

This allows Cipla's medicines to fully cover Sun Pharmaceutical's.

In the case that the cost of both sides is not too much, Cipla has more and better drugs, and is naturally in an advantageous position in the market competition

Cipla was also ruthless, and the shareholders made a decision to kill Sun Pharmaceutical even if no dividends were paid for two years.

Therefore, they decided to reduce the price of some medicines in China, which is aimed at Sun Pharmaceutical.

After the news broke, Sun Pharmaceutical's stock price fell a lot again.

At this time, Sun Pharmaceutical began to panic. They wanted to negotiate with Cipla.

But it didn't work.

Looking for upper-level public relations, Cipla is also a local pharmaceutical company, and now has a greater competitive advantage,

How can the top support Sun Pharmaceutical?

Ask other colleagues to help, but the other colleagues are also silent.

They are all worried that Sun Pharma is also imitating their patented medicines in advance

After all, the reputation of Sun Pharma is already king!

Cipla stepped up its suppression and wanted to merge Sun Pharmaceutical!

In the box of a hotel in Bingcheng, Fu Liang and his father entertained Zheng Xianmin, the new chairman of Bingcheng Pharmaceutical Group.

"Uncle Zheng, thank you for your help this time, I was able to get so many patent licenses at such a low price, and I was also allowed to resell.

"To say thank you, I have more to thank you.

Zheng Xianmin and Fu Liang clink glasses:

If it wasn't for the help of Fu Liang and his son, he would not have been able to obtain the patent authorization of so many top international pharmaceutical companies, and he would not have been able to make Bingcheng Pharmaceutical Group leap into

For the top three domestic pharmaceutical companies.

It will not become the chairman of the board because of this, and the most important step has been completed.

In the next few years, as long as he works hard and stands on the last shift, he can retire with honor.

At his age, there is no way to go up.

This time, he just introduced the heads of some big pharmaceutical companies to Fu Liang and helped to say some good things.

In fact, few domestic pharmaceutical companies dare to challenge Bingcheng Pharmaceutical Group head-on, and even less dare to challenge Fu Liang.

Fu Liang has pulled Pfizer down. Who dares to say that they are stronger than Pfizer?

If Fu Gao stared at their best-selling drugs for research and development, they would be dumbfounded!

"Uncle Zheng, this order is for you. The cost of the API provided by Cipla should be the lowest in the world, and the quality is absolutely fine.

Zheng Xianmin is overjoyed, this is too important for the development of the company.

Can save a lot of costs and improve profits.

Bingcheng Pharmaceutical Group is now expanding rapidly, and there are not enough APIs

The production capacity of some surrounding pharmaceutical companies is insufficient.

, the further you go to purchase, the price will be much higher

Now that he has the order of Cipra, it also solves his urgent needs.

"Xinming, doesn't your company need it?

Fu Xinming shook his head: "We already have an order, enough, this is for you.

If Ciplacon hadn't provided some APIs at low prices, they wouldn't have helped Cipla get so many patents.

These APIs can reduce the production cost of Xinming Pharmaceutical by another two percentage points, which can also increase some profits again.

, Sun Pharma, I heard that the current situation is very bad, this time you also figured it out.

Zheng Xianmin smiled and put it away: "Then thank you very much.

"It's just that the environment in that country is still the same, what a good market, but unfortunately it can't make much money.

In a market as big as Asan, the money earned is not as good as that of a small country in Nanyang.

427 "Their pharmaceutical companies hardly do new drug research and development, and they have little background, which is doomed that they cannot grow into top pharmaceutical companies.

Fu Liang is not very fond of such pharmaceutical companies. If it is an early stage of the company, it is understandable to do so, but he has already made a lot of money, and he continues to do it.